Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhihang Liu

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cancer Gene Therapy|November 3, 2025
Development and preclinical evaluation of ovNDV-28: a chimeric Newcastle disease virus expressing human IL-2 for cancer therapyTianyan Liu, Zhihang Liu, Dan Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2018
Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in miceZhihang Liu, Han Liu, Pengfei Xu, et al.
Molecular Oncology|February 2, 2021
Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasisShaoyong Peng, Daici Chen, Jian Cai, et al.
Molecular Vision|June 23, 2018
Preoperative profile of inflammatory factors in aqueous humor correlates with postoperative inflammatory response in patients with congenital cataractXiaohang Wu, Zhenzhen Liu, Dongni Wang, et al.
Experimental Cell Research|November 7, 2024
PHLDA1 protects intestinal barrier function via restricting intestinal epithelial cells apoptosis in inflammatory bowel diseaseZiwei Zeng, Yiming Shi, Yonghua Cai, et al.
International Journal of Pharmaceutics|May 28, 2018
A novel fusion protein attenuates collagen-induced arthritis by targeting interleukin 17A and tumor necrosis factor αZhihang Liu, Liying Song, Yunxin Wang, et al.
International Immunopharmacology|June 6, 2024
Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease modelsZhihang Liu, Liying Song, Jiarui Yang, et al.
The Journal of Pathology|November 14, 2022
CXCL16 inhibits epithelial regeneration and promotes fibrosis during the progression of radiation enteritisYanmei Cui, Haiyong Wu, Zhihang Liu, et al.
Journal of Translational Medicine|October 7, 2025
A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice modelLiying Song, Sumin Tang, Xuelei Pi, et al.
Gene Therapy|May 17, 2025
Recombinant oncolytic virus NDV-anti-VEGFR2 enhances radiotherapy sensitivity in NSCLC by targeting VEGF signaling and impairing DNA repairLiang Liu, Liying Song, Tianyan Liu, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancer Gene Therapy|November 3, 2025
Development and preclinical evaluation of ovNDV-28: a chimeric Newcastle disease virus expressing human IL-2 for cancer therapyTianyan Liu, Zhihang Liu, Dan Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2018
Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in miceZhihang Liu, Han Liu, Pengfei Xu, et al.
Molecular Oncology|February 2, 2021
Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasisShaoyong Peng, Daici Chen, Jian Cai, et al.
Molecular Vision|June 23, 2018
Preoperative profile of inflammatory factors in aqueous humor correlates with postoperative inflammatory response in patients with congenital cataractXiaohang Wu, Zhenzhen Liu, Dongni Wang, et al.
Experimental Cell Research|November 7, 2024
PHLDA1 protects intestinal barrier function via restricting intestinal epithelial cells apoptosis in inflammatory bowel diseaseZiwei Zeng, Yiming Shi, Yonghua Cai, et al.
International Journal of Pharmaceutics|May 28, 2018
A novel fusion protein attenuates collagen-induced arthritis by targeting interleukin 17A and tumor necrosis factor αZhihang Liu, Liying Song, Yunxin Wang, et al.
International Immunopharmacology|June 6, 2024
Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease modelsZhihang Liu, Liying Song, Jiarui Yang, et al.
The Journal of Pathology|November 14, 2022
CXCL16 inhibits epithelial regeneration and promotes fibrosis during the progression of radiation enteritisYanmei Cui, Haiyong Wu, Zhihang Liu, et al.
Journal of Translational Medicine|October 7, 2025
A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice modelLiying Song, Sumin Tang, Xuelei Pi, et al.
Gene Therapy|May 17, 2025
Recombinant oncolytic virus NDV-anti-VEGFR2 enhances radiotherapy sensitivity in NSCLC by targeting VEGF signaling and impairing DNA repairLiang Liu, Liying Song, Tianyan Liu, et al.
Pageof 6